Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Mallinckrodt
Pharma
Troubled Mallinckrodt, Endo telegraph $6.7B merger plans
After grappling with bankruptcy bids and opioid settlements, Endo and Mallinckrodt are uniting to carve out a brighter future as a combined company.
Fraiser Kansteiner
Mar 13, 2025 10:18am
BMJ report digs into Mallinckrodt's opioid selling tactics
Jun 10, 2024 6:30pm
Mallinckrodt wins court go-ahead for 2nd bankruptcy
Oct 11, 2023 10:55am
After $1.7B opioid deal, Mallinckrodt readies 2nd bankruptcy bid
Aug 23, 2023 2:19pm
Troubled Mallinckrodt continues to weigh its financial options
Aug 9, 2023 9:24am
Mallinckrodt faces lawsuit for allegedly misleading investors
Jul 14, 2023 10:10am
